Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Pharmaceutics|September 27, 2017
Performance comparison between crystalline and co-amorphous salts of indomethacin-lysineGeorgia Kasten, Khatera Nouri, Holger Grohganz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 12, 2018
Whey proteins as stabilizers in amorphous solid dispersionsJaya Mishra, Adam Bohr, Thomas Rades, et al.
Molecular Pharmaceutics|May 24, 2014
Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stabilityRiikka Laitinen, Korbinian Löbmann, Holger Grohganz, et al.
International Journal of Pharmaceutics|January 18, 2018
Is there a correlation between the glass forming ability of a drug and its supersaturation propensity?Lasse Ingerslev Blaabjerg, Eleanor Lindenberg, Korbinian Löbmann, et al.
Pharmaceutics|February 26, 2025
Mechanistic Investigation into Crystallization of Hydrated Co-Amorphous Systems of Flurbiprofen and LidocaineXiaoyue Xu, Holger Grohganz, Justyna Knapik-Kowalczuk, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 13, 2017
Solid state properties and drug release behavior of co-amorphous indomethacin-arginine tablets coated with Kollicoat® ProtectIna Petry, Korbinian Löbmann, Holger Grohganz, et al.
International Journal of Pharmaceutics|April 19, 2018
Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditionsIna Petry, Korbinian Löbmann, Holger Grohganz, et al.
Molecular Pharmaceutics|July 19, 2018
The Role of Glass Transition Temperatures in Coamorphous Drug-Amino Acid FormulationsEric Ofosu Kissi, Georgia Kasten, Korbinian Löbmann, et al.
Pageof 12